Attempted Suicide Short Intervention Program: a Randomized Controlled Trial
NCT03732300 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2024-05-08
Summary
"Attempted Suicide Short Intervention Program" (ASSIP) is a brief psychotherapy intervention after suicide attempts in psychiatric patients. The study aims to analyse the efficacy in a controlled trial by comparing number of patients with suicide attempts in a control group with treatment as usual and an intervention group with treatment as usual and ASSIP intervention.
Further, the study aims at indentifying electrophysiological, sociodempgraphical or smartphone-derived parameters for prediction of further suicide attempts.
Conditions
- Suicidality
- Suicide, Attempted
Interventions
- OTHER
-
ASSIP
Three PSychotherapy Sessions plus after 3/6/9/12 months individualized letters
Sponsors & Collaborators
-
University of Zurich
lead OTHER
Principal Investigators
-
Sebastian Olbrich · Department for Psychiatry, Psychotherapy and Psychosomatics, University Zurich
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-12-01
- Primary Completion
- 2023-02-28
- Completion
- 2023-11-01
Countries
- Switzerland
Study Locations
More Related Trials
-
Injectable Naltrexone Treatment of Alcohol Dependence in Serious Mental Illness (SMI)
NCT00453609 ·Status: COMPLETED ·Phase: PHASE4
-
Injectable Versus Oral Naltrexone Treatment of Alcohol Dependence In Serious Mental Illness (SMI)
NCT00453804 ·Status: COMPLETED ·Phase: PHASE4
-
Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder
NCT06160232 ·Status: RECRUITING ·Phase: PHASE2
-
Clinical and Mechanistic Effects of Psilocybin in Alcohol Addicted Patients
NCT04141501 ·Status: COMPLETED ·Phase: PHASE2
-
A Targeted, Real-Time, Technology-Supported Intervention for Patients With Alcohol Use Disorder on Disulfiram
NCT03543735 ·Status: COMPLETED ·Phase: NA
-
Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder
NCT07296094 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2
-
Trial of the Rapid Antisuicidal Effects of Intranasal Ketamine in Comorbid Depression and Alcohol Abuse
NCT03539887 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of the Screen, Test, Immunize, Reduce Risk, and Refer (STIRR) Intervention for People With Both a Mental and Substance Abuse Disorder
NCT00316303 ·Status: COMPLETED ·Phase: PHASE2
-
Learning to Resist the Urge: Inhibition Training in Abstinent Patients With Alcohol Use Disorders
NCT02968537 ·Status: COMPLETED ·Phase: NA
-
A Randomized Controlled Trial of Structured Stepped-care Intervention for Psychiatric Comorbidity
NCT01941693 ·Status: COMPLETED ·Phase: NA
-
Fluoxetine and Bupropion to Treat Patients With Depression and Alcoholism
NCT00449007 ·Status: TERMINATED ·Phase: PHASE4
-
Apremilast for Alcohol Use Disorder Treatment in Women and Men
NCT06324435 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
Deep Brain Stimulation to Understand and Treat Addiction
NCT07341230 ·Status: RECRUITING ·Phase: NA
-
Phase 2 Study of Apremilast in Women and Men With Alcohol Use Disorder
NCT07029529 ·Status: RECRUITING ·Phase: PHASE2
-
Promoting Medications for Alcohol Use Disorder on the General Medicine Service
NCT04287790 ·Status: TERMINATED
-
Usefulness of Supportive Text Messages in the Treatment of Depressed Alcoholics
NCT01037868 ·Status: COMPLETED ·Phase: NA
-
High-dose Accelerated Theta Burst Stimulation for the Treatment of Alcohol Addiction
NCT05738174 ·Status: RECRUITING ·Phase: NA
-
Ketamine-Enhanced Therapy for Individuals With Alcohol Use Disorder and Depression: A Pilot Study (KET-DUAL)
NCT07247370 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1/PHASE2
-
Training Inhibition in Alcohol Use Disorder
NCT03530384 ·Status: COMPLETED ·Phase: NA
-
Treatment of Young Adults With Comorbid AUD/MDD: A Pilot Medication Trial
NCT02646449 ·Status: COMPLETED ·Phase: PHASE2
-
ACT_for Alcohol Use Disorder and Depression
NCT06620276 ·Status: RECRUITING ·Phase: NA
-
Human Laboratory Study of Apremilast for Alcohol Use Disorder
NCT07325266 ·Status: RECRUITING ·Phase: PHASE2
-
A Clinical Trial for Self-Injurious Behavior
NCT03995966 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Defining the Clinical Role of Topiramate in the Treatment of Alcohol Dependence in Australia
NCT03479086 ·Status: UNKNOWN ·Phase: PHASE3
-
Zonisamide Treatment of Alcohol Use Disorder: an Evaluation of Efficacy and Mechanism of Action
NCT02900352 ·Status: COMPLETED ·Phase: PHASE3